Table 1. EQA results of the 28 participant laboratories in the molecular diagnosis panel.
Sample ID | #2 | #9 | #12 | #4 | #14 | #10 | #5 | #13 | #1 | #6 | #11 | #3 | #8 | #7 | ||||
Viral load in sample | 3×106 | 3×105 | 3×104 | 3×103 | 3×102 | 104 | 103 | 2×104 | 2×103 | 69 | NEG | NEG | NEG | NEG | ||||
Lab. no. | RT-PCR technique | 17D | 17D | 17D | 17D | 17D | Brazil | Brazil | Ivory Coast | Ivory Coast | Ivory Coast | SLEV/JEVWNV/TBEV | DENV1-4 | neg | neg | TARGET | Score* | Classification |
16a | TaqMan RT-PCRa | + | + | + | + | + | + | + | + | + | (−) | − | − | − | − | YFV | 26 | OPTIMAL |
8 | TaqMan RT-PCRb | + | + | + | + | (−) | + | + | + | + | (−) | − | − | − | − | PANFLAV | 24¶ | OPTIMAL |
17b | RT nested PCRc | + | + | + | + | + | + | + | + | + | + | − | (+) | − | − | PANFLAV | 24¶ | NON OPTIMAL |
1 | TaqMan RT-PCRa | + | + | + | + | + | + | + | + | + | + | − | (+) | − | − | YFV | 24 | NON OPTIMAL |
27 | TaqMan RT-PCRd | + | + | + | + | + | + | + | + | + | + | − | (+) | − | − | YFV | 24 | NON OPTIMAL |
28 | TaqMan RT-PCRe | + | + | + | + | + | + | + | + | + | + | − | (+) | − | − | YFV | 24 | NON OPTIMAL |
15 | TaqMan RT-PCRa | + | + | + | + | + | + | + | + | + | (−) | − | (+) | − | − | YFV | 22 | NON OPTIMAL |
17a | TaqMan RT-PCRf | + | + | + | + | + | + | + | + | + | (−) | − | (+) | − | − | YFV | 22 | NON OPTIMAL |
6 | RT nested PCRx | + | + | (−) | (−) | (−) | + | + | + | + | (−) | − | − | − | − | PANFLAV | 20¶ | OPTIMAL |
22a | RT nested PCRg | + | + | ND | + | (−) | + | + | (−) | (−) | + | − | − | − | − | PANFLAV | 20¶ | OPTIMAL |
16b | Heminest Rt-PCRc | + | + | + | + | + | + | + | + | + | (−) | − | (+) | − | − | PANFLAV | 20¶ | NON OPTIMAL |
2 | TaqMan RT-PCRa | + | + | + | + | (−) | + | + | + | + | (−) | − | (+) | − | − | YFV | 20 | NON OPTIMAL |
9 | TaqMan RT-PCRa | + | + | + | + | (−) | + | + | + | + | (−) | − | (+) | − | − | YFV | 20 | NON OPTIMAL |
14 | RT nested PCRg | + | + | + | (−) | (−) | + | (−) | + | (−) | (−) | − | − | − | − | PANFLAV | 18¶ | OPTIMAL |
4 | TaqMan RT-PCRa | + | + | + | + | (−) | + | + | + | (−) | (−) | − | (+) | − | − | YFV | 18 | NON OPTIMAL |
10 | TaqMan RT-PCRe | + | + | + | + | + | (−) | (−) | (−) | (−) | (−) | − | (+) | − | − | YFV | 14 | NON OPTIMAL |
11 | RT-PCRh | + | + | + | + | + | (−) | (−) | (−) | (−) | (−) | − | (+) | − | − | YFV | 14 | NON OPTIMAL |
20 | Heminest RT-PCRc | + | + | + | + | + | + | + | + | + | + | (+) | (+) | − | (+) | PANFLAV | 16¶ | NON OPTIMAL |
3b | TaqMan RT-PCRe | + | + | + | + | + | (−) | (−) | (−) | (−) | (−) | − | (+) | − | − | YFV | 14 | NON OPTIMAL |
5 | TaqMan RT-PCRx | + | + | + | + | + | (−) | (−) | (−) | (−) | (−) | − | (+) | − | − | YFV | 14 | NON OPTIMAL |
13 | TaqMan RT-PCRa | + | + | ND | + | + | (−) | (−) | + | (−) | (−) | − | (+) | − | − | YFV | 14 | NON OPTIMAL |
18 | TaqMan RT-PCRe | + | + | + | + | + | (−) | (−) | (−) | (−) | (−) | (+) | − | − | − | YFV | 14 | NON OPTIMAL |
3a | RT nested PCRf | + | + | + | (−) | (−) | + | (−) | (−) | (−) | (−) | − | (+) | − | − | YFV | 12 | NON OPTIMAL |
19 | TaqMan RT-PCRa | + | + | + | (−) | (−) | + | (−) | (−) | (−) | (−) | − | (+) | − | − | YFV | 12 | NON OPTIMAL |
22b | TaqMan RT-PCRe | + | + | ND | + | + | (−) | (−) | (−) | (−) | (−) | − | (+) | − | − | YFV | 12 | NON OPTIMAL |
7 | TaqMan RT-PCRi | + | + | + | + | + | + | (−) | (−) | (−) | + | (+) | (+) | − | (+) | YFV | 10 | NON OPTIMAL |
21 | TaqMan RT-PCRe | + | + | + | (−) | (−) | (−) | (−) | (−) | (−) | (−) | − | (+) | − | − | YFV | 10 | NON OPTIMAL |
25 | RT-nested PCRx | + | (−) | (−) | (−) | (−) | ND | (−) | (−) | ND | (−) | − | − | − | − | YFV | 8 | NON OPTIMAL |
12 | SYBR-RT-PCRb | + | + | + | (−) | (−) | + | (−) | (−) | + | (−) | (+) | (+) | (+) | − | PANFLAV | 6 | NON OPTIMAL |
23 | RT-PCRj | + | + | + | (−) | (−) | + | (−) | (−) | (−) | (−) | − | (+) | − | − | PANFLAV | 0 | NON OPTIMAL |
24 | RT-nested PCRk | (−) | (−) | (−) | (−) | (−) | (−) | (−) | (−) | (−) | (−) | − | − | − | − | YFV | NS | NON OPTIMAL |
26 | RT-nested PCRf | + | (−) | (−) | + | (−) | (−) | + | (−) | + | + | (+) | (+) | (+) | (+) | YFV | NS | NON OPTIMAL |
CORRECT RESULTS (%) | 96.8 | 90.6 | 86.2 | 71.8 | 53.1 | 67.7 | 50 | 50 | 48.3 | 25 | 84.3 | 25 | 93.7 | 93.7 |
The score reflects the quality of the diagnostic results: +, positive result (score 2 points); (+), false positive (score -2 points); −, correct negative result (score 2 points); (−), false negative (score 0 points).
[20];
adapted from [23];
[19];
[24];
[21];
in-house;
[18];
[22];
[16];
[15];
[17];
not provided.
Sequencing performed; NS: Negative Score; ND: not done; PANFLAV: panflavivirus; YFV: yellow fever virus.